8-K: TruBridge Announces Fourth Quarter and Full Year 2024 Results, Provides Initial 2025 Outlook

TruBridge, Inc. reported its fourth quarter and full year 2024 financial results, highlighting revenue of $339.2 million for the year and providing an initial 2025 outlook.

Summary

• TruBridge, Inc. announced its financial results for the fourth quarter and year ended December 31, 2024.
• The company reported revenue of $339.2 million for 2024 and $87.4 million for the fourth quarter.
• TruBridge experienced a net loss of $23.1 million for 2024 and $5.7 million for the fourth quarter.
• Adjusted EBITDA was $53.1 million for 2024 and $17.2 million for the fourth quarter.
• Total annual bookings reached $82.1 million.
• The company successfully divested American Health Tech (AHT).
• TruBridge expects total revenue between $345 million and $360 million and adjusted EBITDA between $59 million and $66 million for the full year 2025.
• For the first quarter of 2025, TruBridge anticipates total revenue between $85 million and $88 million and adjusted EBITDA between $14 million and $16 million.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While the company reported a net loss, it also showed growth in adjusted EBITDA and bookings, along with a strategic divestiture and a positive outlook for 2025. Management's comments are optimistic, but the risks and challenges mentioned temper the overall sentiment.

Positives

• TruBridge achieved solid organic growth in its Financial Health business.
• The company improved its financial results, forecasting accuracy, and capital allocation strategy.
• TruBridge transitioned approximately 30% of its Financial Health Complete Business Office (CBO) client base offshore.
• The company improved cash flows with significant debt repayment, reducing the leverage ratio.
• TruBridge successfully divested American Health Tech (AHT).
• Recurring revenue represented 94.4% of total revenue for the full year 2024.
• Adjusted EBITDA increased from $47.6 million in 2023 to $53.1 million in 2024.

Negatives

• TruBridge reported a net loss of $23.1 million for 2024.
• Total revenue for 2024 was $339.2 million, slightly below the $339.4 million reported in 2023.
• Total bookings for the fourth quarter were $14.3 million, compared to $24.4 million in the same quarter of the previous year.
• Patient Care revenue decreased from $145.5 million in 2023 to $123.1 million in 2024.

Risks

• The company faces risks related to market saturation, hospital consolidations, and unfavorable economic conditions.
• Significant legislative and regulatory uncertainty in the healthcare industry could impact TruBridge's performance.
• Competition from companies with greater financial, technical, and marketing resources poses a risk.
• Potential future acquisitions may be expensive and time-consuming.
• The company's substantial indebtedness and restrictive terms of its credit agreement could impact operations.
• Macroeconomic conditions, including bank failures or changes in related regulation, could have material adverse effects.

Future Outlook

TruBridge expects total revenue between $345 million and $360 million and adjusted EBITDA between $59 million and $66 million for the full year 2025. For the first quarter of 2025, the company anticipates total revenue between $85 million and $88 million and adjusted EBITDA between $14 million and $16 million.

Management Comments

• Chris Fowler, CEO of TruBridge, stated he is proud of the progress made in 2024 and pleased to be reporting revenue and adjusted EBITDA ahead of expectations.
• Fowler noted the company has strengthened its financial operations and executed key strategic initiatives.
• Looking ahead to 2025, Fowler stated the company is focused on enhancing customer satisfaction and retention, optimizing operations, and expanding the sales pipeline.

Industry Context

TruBridge operates in the healthcare solutions industry, providing technology-first solutions to healthcare organizations. The company's focus on revenue cycle management (RCM) and electronic health record (EHR) offerings aligns with the industry's ongoing efforts to improve financial and clinical outcomes. The divestiture of AHT suggests a strategic shift towards a more focused approach on its core business segments.

Comparison to Industry Standards

• Comparing TruBridge's performance to industry peers requires a deeper dive into specific growth rates and profitability metrics.
• Companies like R1 RCM and OptumInsight are major players in the RCM space, and their revenue growth and EBITDA margins could serve as benchmarks.
• In the EHR market, companies like Cerner (now part of Oracle) and Epic Systems are dominant, but TruBridge focuses on serving smaller healthcare organizations.
• TruBridge's adjusted EBITDA margin of 15.7% for 2024 is a key metric to compare against industry averages.
• The company's recurring revenue rate of over 90% is a positive indicator of stability and predictability, which is often valued by investors.

Management Changes

Stakeholder Impact

• Shareholders may be impacted by the company's financial performance and strategic decisions.
• Employees may be affected by the company's restructuring and business transformation initiatives.
• Customers can expect continued investment in customer satisfaction and retention.
• Suppliers and creditors may be impacted by the company's financial health and debt repayment efforts.

Next Steps

• TruBridge will hold a conference call and live webcast on March 10, 2025, to discuss the results.
• The company will focus on enhancing customer satisfaction and retention, optimizing operations, and expanding its sales pipeline in 2025.
• TruBridge will continue to invest in its offshore capabilities and innovation.

Key Dates